To view this email as a web page, click here.

 
I prescribe drugs off-label. Am I in violation of FDA regulations?
In a CME session through your local dermatology society, a prominent drug company provides journal articles documenting the off-label use of one of their prescription pharmaceutical agents. You obtain CME credits, read the journal article and begin prescribing the off-label medication. Is the drug company in violation of the U.S. Food and Drug Administration rulings?
Are your actions acceptable?
ADVERTISEMENT
 
How to avoid litigation associated with fillers
A review of complications associated with injectable fillers published in JAMA Facial Plastic Surgery shows that swelling and infection remain the most common of adverse events, but more serious events occur as well, serving as a reminder to carefully review pre-operative informed consent documents with patients, the authors state.
Learn More.
ADVERTISEMENT
 
JOB OPPORTUNITIES
 
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.